Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
Dr.’s Aryan Sarparast, Chris Stauffer, Kelan Thomas, and Benjamin Malcolm, recently published the first systematic review of drug interactions between psychiatric medications and psychedelics: “Drug-drug interactions between psychiatric medications and MDMA or psilocybin: A systematic review.” In this article, the authors offer a synopsis of their systematic review.
This articles highlights conservation issues around Tabernanthe iboga, sacred plant medicine of the Bwiti and a common source of ibogaine used in the treatment of addictions.
How can the use of psychedelic and sacred plants help alleviate human suffering? What are the barriers to such “plant medicines,” like ayahuasca, becoming...
What is the connection between ayahuasca and epigenetics? In this study, the researchers explored whether ayahuasca could be used as a treatment for developmental trauma.
When someone is diagnosed with a severe, life-threatening illness, the affected individual may begin to ask several existential questions. The author, Lucas Maia, PhD, summarizes his findings from his doctoral thesis which studied the ritual use of ayahuasca and its therapeutic potential for those facing and fearing death.
Simon Ruffell, et.al. provide a systematic review of the pharmacological interaction of chemical compounds in ayahuasca. The researchers wanted to better understand which chemicals in ayahuasca are required to achieve positive outcomes, questions remain regarding which components are essential, how they interact, and what happens if they are removed.